Cooper Companies (COO) vs RxSight (RXST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cooper Companies (COO) has outperformed RxSight (RXST) over the past year, losing 20.7% versus a loss of 42.0%. Over five years, COO leads with a -45.0% price change compared with -64.6% for RXST. Cooper Companies is the larger company by market cap ($10.41 billion vs $199.6 million), about 52.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COO | RXST |
|---|---|---|
| Share price | $54.75 | $4.80 |
| Market cap | $10.41B | $199.65M |
| 1-day change | -2.98% | +3.23% |
| YTD return | -33.20% | -53.93% |
| 1-year return | -20.68% | -42.03% |
| 5-year return | -45.02% | -64.60% |
| P/E ratio (TTM) | 18.81 | — |
| Forward P/E | 11.67 | — |
| EPS (TTM) | $2.91 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.09B | — |
| Revenue growth (YoY) | +5.06% | — |
| Net income (latest FY) | $374.90M | — |
| Gross margin | 65.54% | — |
| Operating margin | 16.69% | — |
| Net margin | 9.16% | — |
| 52-week high | $89.83 | $13.22 |
| 52-week low | $51.01 | $4.48 |
| Distance from 52-week high | -39.05% | -63.69% |
| Analyst consensus | hold | none |
| Avg. price target upside | +20.18% | +57.71% |
| Average volume | 3.13M | 861.57K |
| Shares outstanding | 190.16M | 41.59M |
| Employees | 15,000 | 461 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cooper Companies is about 52.1 times larger than RxSight by market value ($10.41B vs $199.65M).
- COO has outperformed RXST by 21.4 percentage points over the past year.
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Health Care · Ophthalmic Goods · 15,000 employees
About RxSight
RXST stock →RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Health Care · Ophthalmic Goods · 461 employees
COO vs RXST FAQ
Which is bigger, Cooper Companies or RxSight?
Cooper Companies (COO) is larger, with a market capitalization of $10.41B compared with $199.65M for RxSight (RXST).
Which stock has performed better over the past year, COO or RXST?
COO returned -20.68% over the past 12 months, compared with -42.03% for RXST (price return, excluding dividends). Past performance does not predict future results.
Are Cooper Companies and RxSight in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.